These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 35318738

  • 21. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM, Al-Shreef FM, Al-Jiffri OH.
    Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
    [Abstract] [Full Text] [Related]

  • 22. Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial.
    Hormoznejad R, Mohammad Shahi M, Rahim F, Helli B, Alavinejad P, Sharhani A.
    Int J Food Sci Nutr; 2020 Dec; 71(8):991-1000. PubMed ID: 32237922
    [Abstract] [Full Text] [Related]

  • 23. The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.
    Zamani N, Shams M, Nimrouzi M, Zarshenas MM, Abolhasani Foroughi A, Fallahzadeh Abarghooei E, Fattahi MR.
    Complement Ther Med; 2018 Dec; 41():118-123. PubMed ID: 30477827
    [Abstract] [Full Text] [Related]

  • 24. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M, Mohd-Yusof BN, Hanipah ZN, Mohd Redzwan S, Yusof LM, Khosroshahi MZ.
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [Abstract] [Full Text] [Related]

  • 25. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial.
    Rezaei S, Akhlaghi M, Sasani MR, Barati Boldaji R.
    Nutrition; 2019 Jan; 57():154-161. PubMed ID: 30170304
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
    Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I.
    Br J Nutr; 2014 Apr 14; 111(7):1263-71. PubMed ID: 24299662
    [Abstract] [Full Text] [Related]

  • 28. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
    Amanat S, Eftekhari MH, Fararouei M, Bagheri Lankarani K, Massoumi SJ.
    Clin Nutr; 2018 Aug 14; 37(4):1210-1215. PubMed ID: 28647291
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Rosemary (Rosmarinus officinalis L.) essential oil alleviates testis failure induced by Etoposide in male rats.
    Saied M, Ali K, Mosayeb A.
    Tissue Cell; 2023 Apr 14; 81():102016. PubMed ID: 36640564
    [Abstract] [Full Text] [Related]

  • 32. Olive Leaf Extract Supplementation Combined with Calorie-Restricted Diet on Reducing Body Weight and Fat Mass in Obese Women: Result of a Randomized Control Trial.
    Haidari F, Shayesteh F, Mohammad-Shahi M, Jalali MT, Ahmadi-Angali K.
    Clin Nutr Res; 2021 Oct 14; 10(4):314-329. PubMed ID: 34796136
    [Abstract] [Full Text] [Related]

  • 33. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G.
    BMC Complement Altern Med; 2019 Mar 12; 19(1):59. PubMed ID: 30871514
    [Abstract] [Full Text] [Related]

  • 34. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F, Adibi P, Hekmatdoost A.
    Br J Nutr; 2015 Sep 14; 114(5):796-803. PubMed ID: 26234526
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Rafie R, Hosseini SA, Hajiani E, Saki Malehi A, Mard SA.
    Clin Exp Gastroenterol; 2020 Sep 14; 13():35-45. PubMed ID: 32158249
    [Abstract] [Full Text] [Related]

  • 37. [Change in plasma nesfatin-1 concentration within high-fat diet induced nonalcoholic fatty liver disease rat models].
    Wu R, Chen Z, Xu Y, Ge J, Lü X.
    Wei Sheng Yan Jiu; 2016 May 14; 45(3):452-7. PubMed ID: 27459811
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Cheraghpour M, Imani H, Ommi S, Alavian SM, Karimi-Shahrbabak E, Hedayati M, Yari Z, Hekmatdoost A.
    Phytother Res; 2019 Aug 14; 33(8):2118-2125. PubMed ID: 31264313
    [Abstract] [Full Text] [Related]

  • 40. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.
    Sangouni AA, Mohammad Hosseini Azar MR, Alizadeh M.
    Br J Nutr; 2020 Aug 28; 124(4):450-456. PubMed ID: 32312333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.